| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pulmonary Edema | D011654 | 23 associated lipids |
| Pulmonary Embolism | D011655 | 5 associated lipids |
| Coronary Disease | D003327 | 70 associated lipids |
| Liver Cirrhosis, Experimental | D008106 | 36 associated lipids |
| Hypersensitivity | D006967 | 22 associated lipids |
| Hypothyroidism | D007037 | 32 associated lipids |
| Rhinitis | D012220 | 10 associated lipids |
| Hypercapnia | D006935 | 5 associated lipids |
| Arterial Occlusive Diseases | D001157 | 12 associated lipids |
| Pain, Postoperative | D010149 | 13 associated lipids |
| Asthma | D001249 | 52 associated lipids |
| Kidney Diseases | D007674 | 29 associated lipids |
| Femoral Fractures | D005264 | 7 associated lipids |
| Weight Gain | D015430 | 101 associated lipids |
| Hyperemia | D006940 | 25 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Acidosis | D000138 | 13 associated lipids |
| Glioma | D005910 | 112 associated lipids |
| Staphylococcal Infections | D013203 | 15 associated lipids |
| Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Barnett AH et al. | Specific thromboxane synthetase inhibition and albumin excretion rate in insulin-dependent diabetes. | 1984 | Lancet | pmid:6145027 |
| Schenkelaars EJ and Bonta IL | Beta 2-adrenoceptor agonists reverse the leukotriene C4-induced release response of macrophages. | 1984 | Eur. J. Pharmacol. | pmid:6151905 |
| Kopolovic R et al. | Effects of ibuprofen on a porcine model of acute respiratory failure. | 1984 | J. Surg. Res. | pmid:6708494 |
| Schenkein HA and Rutherford B | C3-mediated release of prostaglandin from human monocytes. Behaviour in short-term culture. | 1984 | Immunology | pmid:6690398 |
| Hamasaki Y et al. | Platelet-activating factor raises airway and vascular pressures and induces edema in lungs perfused with platelet-free solution. | 1984 | Am. Rev. Respir. Dis. | pmid:6547031 |
| Gallenkämper W et al. | Cardioprotective actions of pentoxifylline in an animal model of acute myocardial ischaemia. | 1984 | Br. J. Pharmacol. | pmid:6547067 |
| Coker SJ and Parratt JR | The effects of timolol on arrhythmias and prostanoid release during canine myocardial ischaemia and reperfusion. | 1984 | Br. J. Pharmacol. | pmid:6547068 |
| Navran SS et al. | Human platelet activation by bacterial phospholipase C is mediated by phosphatidylinositol hydrolysis but not generation of phosphatidic acid: inhibition by a selective inhibitor of phospholipase C. | 1984 | Thromb. Res. | pmid:6372157 |
| Furman BL et al. | Failure of drugs that selectively inhibit thromboxane synthesis to modify endotoxin shock in conscious rats. | 1984 | Br. J. Pharmacol. | pmid:6375795 |
| Merola AJ et al. | Prostaglandin response in the exercise conditioned rat. | 1984 | Prostaglandins Leukot Med | pmid:6377328 |
| D'Angelo A et al. | Increased production of platelet thromboxane B2 in non-insulin-dependent diabetes. Relationship to vascular complications. | 1984 | Eur. J. Clin. Invest. | pmid:6428908 |
| Schenkein HA and Rutherford RB | Effects of serum on C3b-stimulated release of prostaglandins and thromboxane B2 from human monocytes. | 1984 | Immunopharmacology | pmid:6511367 |
| Fung WP et al. | Effect of ethanol on gastric secretion of thromboxane B2. | 1984 | Med. J. Malaysia | pmid:6513851 |
| Hänsch GM et al. | Macrophages release arachidonic acid, prostaglandin E2, and thromboxane in response to late complement components. | 1984 | J. Immunol. | pmid:6432907 |
| Rachmilewitz D and Karmeli F | Effect of nufenoxole on human colonic prostanoid synthesis, Na-K-ATPase and adenylate cyclase activities. | 1984 | Eur. J. Pharmacol. | pmid:6152213 |
| Stock JL and Coderre JA | Calcitonin enhances production of prostaglandins by stimulated human monocytes. | 1984 | Prostaglandins | pmid:6087420 |
| Yui Y et al. | Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation. | 1984 | Circulation | pmid:6434196 |
| Vesterqvist O et al. | Development of a GC-MS method for quantitation of 2,3-dinor-TxB2 and determinations of the daily urinary excretion rates in healthy humans. | 1984 | Thromb. Res. | pmid:6695361 |
| Davì G et al. | Platelet function changes in acute myocardial infarction. | 1984 | Adv. Exp. Med. Biol. | pmid:6695571 |
| Mehta J et al. | Thromboxane release in coronary artery disease: spontaneous versus pacing-induced angina. | 1984 | Am. Heart J. | pmid:6695662 |
| Klotz TA et al. | Urinary excretion of thromboxane B2 in patients with venous thromboembolic disease. | 1984 | Chest | pmid:6697787 |
| Dembinska-Kieć A et al. | Formation of leukotriene C4-like material by rat brain tissue. | 1984 | Eur. J. Pharmacol. | pmid:6426980 |
| Stuart MJ et al. | Effects of hyperoxia and hypoxia on vascular prostacyclin formation in vitro. | 1984 | Pediatrics | pmid:6435087 |
| Vergani CG et al. | Bile lipid composition and haemostatic variables in a case of high density lipoprotein deficiency (Tangier disease). | 1984 | Eur. J. Clin. Invest. | pmid:6421598 |
| Morrison AR and Crowley JR | Identification of an unusual cyclooxygenase metabolite of arachidonic acid in rabbit renal medulla. | 1984 | Arch. Biochem. Biophys. | pmid:6437329 |
| Oglesby TD and Gorman RR | The inhibition of arachidonic acid metabolism in human platelets by RHC 80267, a diacylglycerol lipase inhibitor. | 1984 | Biochim. Biophys. Acta | pmid:6424715 |
| Marks JG et al. | Contact urticaria and airway obstruction from carbonless copy paper. | 1984 Aug 24-31 | JAMA | pmid:6235381 |
| MacNab MW et al. | The effects of a new thromboxane synthetase inhibitor, CGS-13080, in man. | 1984 Feb-Mar | J Clin Pharmacol | pmid:6371062 |
| Buchanan MR and Hirsh J | Effect of aspirin and salicylate on platelet-vessel wall interactions in rabbits. | 1984 Jul-Aug | Arteriosclerosis | pmid:6380468 |
| Paajanen H et al. | Modification of platelet aggregation and thromboxane synthesis by intravascular contrast media. | 1984 Jul-Aug | Invest Radiol | pmid:6434489 |
| De Caterina R et al. | Thromboxane-B2 generation during ex-vivo platelet aggregation. | 1984 Jul-Sep | J. Nucl. Med. Allied Sci. | pmid:6530623 |
| Egg D | Concentrations of prostaglandins D2, E2, F2 alpha, 6-keto-F1 alpha and thromboxane B2 in synovial fluid from patients with inflammatory joint disorders and osteoarthritis. | 1984 Mar-Apr | Z Rheumatol | pmid:6730731 |
| Tanabe M et al. | Inhibition of coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion by 2-phenylaminoadenosine (CV-1808) in anesthetized dogs. | 1984 May-Jun | J. Cardiovasc. Pharmacol. | pmid:6202970 |
| Laustiola K et al. | Exercise-induced increase in plasma arachidonic acid and thromboxane B2 in healthy men: effect of beta-adrenergic blockade. | 1984 May-Jun | J. Cardiovasc. Pharmacol. | pmid:6202971 |
| Sturm M et al. | The measurement of plasma thromboxane B2 and the effect of smoking. | 1984 Nov-Dec | Clin. Exp. Pharmacol. Physiol. | pmid:6536421 |
| Menitove JE et al. | Use of prostacyclin to inhibit activation of platelets during preparation of platelet concentrates. | 1984 Nov-Dec | Transfusion | pmid:6390814 |
| Fisher M et al. | Selective thromboxane inhibition: a new approach to antiplatelet therapy. | 1984 Sep-Oct | Stroke | pmid:6474531 |
| Uderman HD et al. | Thromboxane synthetase inhibitor UK38,485 lowers blood pressure in the adult spontaneously hypertensive rat. | 1984 Sep-Oct | J. Cardiovasc. Pharmacol. | pmid:6209508 |
| Ahlsten G et al. | Aggregation of and thromboxane B2 synthesis in platelets from newborn infants of smoking and non-smoking mothers. | 1985 | Prostaglandins Leukot Med | pmid:3863152 |
| Mehta J et al. | Increase in human platelet alpha 2-adrenergic receptor affinity for agonist in unstable angina. | 1985 | J. Lab. Clin. Med. | pmid:2866219 |
| Greer IA et al. | A comparative study of the effects of adrenoceptor antagonists on platelet aggregation and thromboxane generation. | 1985 | Thromb. Haemost. | pmid:2867620 |
| Yardumian DA et al. | Platelet hyperaggregability occurring during prolonged continuous intravenous infusions of prostacyclin analogue ZK 36374. | 1985 | Br. J. Haematol. | pmid:2408653 |
| Patrassi GM et al. | Contact phase of coagulation in diabetes mellitus after aspirin administration. | 1985 | Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. | pmid:2410343 |
| Safai-Kutti S et al. | Plasma concentrations of platelet-specific proteins and serum thromboxane B2 production in response to treatment with dipyridamole. A pilot study of 27 post-myocardial infarction patients. | 1985 | Eur. Heart J. | pmid:2412820 |
| Demling RH et al. | Early lung dysfunction after major burns: role of edema and vasoactive mediators. | 1985 | J Trauma | pmid:2413227 |
| Myśliwiec M et al. | Plasma thromboxane B2 in haemodialysed patients. | 1985 | Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. | pmid:2414174 |
| Schlondorff D and Satriano JA | Interactions of vasopressin, cAMP, and prostaglandins in toad urinary bladder. | 1985 | Am. J. Physiol. | pmid:2579584 |
| Kobayashi H et al. | Effects of 6-keto-prostaglandin E1 on ascitic hepatoma-130 in vivo comparison with chemotherapeutic agents. | 1985 | Prostaglandins | pmid:3920729 |
| Ylitalo P et al. | Inhibition of prostaglandin synthesis by indomethacin interacts with the antihypertensive effect of atenolol. | 1985 | Clin. Pharmacol. Ther. | pmid:3899459 |
| De Caterina R et al. | Low-dose aspirin in patients recovering from myocardial infarction. Evidence for a selective inhibition of thromboxane-related platelet function. | 1985 | Eur. Heart J. | pmid:3930246 |
| Gorczynska E et al. | [Effect of various stimulators on cyclooxygenase activity, platelet aggregation and TxB2 synthesis after using a platelet inhibitor (Aspro Clear) in vivo and in vitro]. | 1985 | Wiad. Lek. | pmid:3933184 |
| Berman B et al. | Interferon enhancement of HLA-DR antigen expression on epidermal Langerhans cells. | 1985 | J. Invest. Dermatol. | pmid:2578172 |
| Shayevitz JR et al. | Inhalation anesthetics augment oxidant-induced pulmonary vasoconstriction: evidence for a membrane effect. | 1985 | Anesthesiology | pmid:3933385 |
| Mehta P et al. | Plasma concentrations of thromboxane and prostacyclin metabolites in patients with bone tumors. | 1985 | Am J Pediatr Hematol Oncol | pmid:2994511 |
| Patrono C et al. | Clinical pharmacology of platelet cyclooxygenase inhibition. | 1985 | Circulation | pmid:3933848 |
| VanRollins M et al. | Metabolism of 7,10,13,16-docosatetraenoic acid to dihomo-thromboxane, 14-hydroxy-7,10,12-nonadecatrienoic acid and hydroxy fatty acids by human platelets. | 1985 | Biochim. Biophys. Acta | pmid:3918572 |
| Gee MH et al. | Eicosanoids, leukocytes and lung injury. | 1985 | Prog. Clin. Biol. Res. | pmid:3934681 |
| Benigni A et al. | Inhibition of human platelet aggregation by parathyroid hormone. Is cyclic AMP implicated? | 1985 | Am. J. Nephrol. | pmid:2996352 |
| Leslie JB and Watkins WD | Eicosanoids in the central nervous system. | 1985 | J. Neurosurg. | pmid:2997413 |
| Darius H et al. | Beneficial effects of a new potent and specific thromboxane receptor antagonist (SQ-29,548) in vitro and in vivo. | 1985 | J. Pharmacol. Exp. Ther. | pmid:2997428 |
| Zavagli G et al. | Platelet aggregation and evaluation of the ratio thromboxane B2/6-keto-prostaglandin F1 alpha in the plasma of patients on long term cimetidine treatment. | 1985 | Prostaglandins Leukot Med | pmid:2997804 |
| Sinzinger H | Double blind study of the influence of co-dergocrine on platelet parameters in healthy volunteers. | 1985 | Eur. J. Clin. Pharmacol. | pmid:2998802 |
| Schambelan M et al. | Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus. | 1985 | J. Clin. Invest. | pmid:3156147 |
| Klotman PE et al. | Captopril enhances aminoglycoside nephrotoxicity in potassium-depleted rats. | 1985 | Kidney Int. | pmid:2422431 |
| Pediconi M et al. | Effects of acute and chronic ethanol administration on thromboxane and prostacyclin levels and release in rat brain cortex. | 1985 | Prostaglandins | pmid:3901122 |
| Neri Serneri GG et al. | Abnormal cardiocoronary thromboxane A2 production in patients with unstable angina. | 1985 | Am. Heart J. | pmid:3984828 |
| Vesterqvist O et al. | In vivo production of thromboxane in acute human myocardial infarction: a preliminary study. | 1985 | Thromb. Res. | pmid:3992528 |
| Wirthumer-Hoche C and Sinzinger H | [Protein binding of thromboxane--one of the sources of error in thromboxane determination]. | 1985 | Wien. Klin. Wochenschr. | pmid:3993037 |
| Croft KD et al. | Onset of changes in phospholipid fatty acid composition and prostaglandin synthesis following dietary manipulation with n-6 and n-3 fatty acids in the rat. | 1985 | Biochim. Biophys. Acta | pmid:3995069 |
| Eldor A et al. | Platelet interaction with subendothelial extracellular matrix: platelet-fibrinogen interactions are essential for platelet aggregation but not for the matrix-induced release reaction. | 1985 | Blood | pmid:3995180 |
| Preud'homme Y et al. | Metabolism of arachidonic acid in rabbit iris and retina. | 1985 | Invest. Ophthalmol. Vis. Sci. | pmid:3930417 |
| Zahavi J and Zahavi M | Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease. | 1985 | Thromb. Haemost. | pmid:3158092 |
| Roy L et al. | Lack of efficacy of nafazatrom, a novel anti-thrombotic compound, in patients with coronary artery disease. | 1985 | Am. Heart J. | pmid:3158183 |
| Pedrinelli R et al. | The influence of selective and nonselective prostaglandin inhibition on renin. | 1985 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:3159197 |
| Ezra D et al. | Effects of platelet-activating factor on coronary hemodynamics and coronary venous plasma levels of TXB2, 6-keto-PGF1 alpha, and leukotriene C4 immunoreactivity in the intact domestic pig heart. | 1985 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:3159202 |
| Gensini GF et al. | Effects of dipyridamole infusion on local platelet aggregation and local formation of thromboxane A2 in patients with pulmonary hypertension. | 1985 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:3159209 |
| De Caterina R et al. | Aspirin after acute myocardial infarction: a systematic approach to compare the hemostatic effects of three different doses. | 1985 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:3159210 |
| Rajtar G et al. | Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors. | 1985 | Biochem. Pharmacol. | pmid:3918536 |
| Valentovic MA and Lubawy WC | Elevated glucose in vivo and in vitro adversely alters prostaglandin generation in rat aortas and platelets. | 1985 | Prostaglandins Leukot Med | pmid:3903777 |
| Nigam S et al. | The concentrations of 6-keto-PGF1 alpha and TXB2 in plasma samples from patients with benign and malignant tumours of the breast. | 1985 | Prostaglandins | pmid:3839084 |
| Petroni A et al. | Differential effects of various vasoactive drugs on basal and stimulated levels of TXB2 and 6-keto-PGF1 alpha in rat brain. | 1985 | Prostaglandins | pmid:3839085 |
| Zipser RD | Effects of selective inhibition of thromboxane synthesis on renal function in humans. | 1985 | Am. J. Physiol. | pmid:3839111 |
| Weisman SM et al. | Platelet-activating factor is a potent stimulus for renal prostaglandin synthesis: possible significance in unilateral ureteral obstruction. | 1985 | J. Pharmacol. Exp. Ther. | pmid:3862805 |
| Fink MP et al. | Low-dose dopamine preserves renal blood flow in endotoxin shocked dogs treated with ibuprofen. | 1985 | J. Surg. Res. | pmid:3839278 |
| Bornman MS et al. | Elevated thromboxane B2 levels during erection. | 1985 | S. Afr. Med. J. | pmid:3839322 |
| Steinhauer HB et al. | Stimulation of peritoneal synthesis of vasoactive prostaglandins during peritonitis in patients on continuous ambulatory peritoneal dialysis. | 1985 | Eur. J. Clin. Invest. | pmid:3921379 |
| DiMinno G et al. | Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane. | 1985 | Blood | pmid:2981130 |
| Gairola C and Tai HH | Selective inhibition of leukotriene B4 biosynthesis in rat pulmonary alveolar macrophages by dietary selenium deficiency. | 1985 | Biochem. Biophys. Res. Commun. | pmid:2998361 |
| Rinaldo JE and Dauber JH | Effect of methylprednisolone and of ibuprofen, a nonsteroidal antiinflammatory agent, on bronchoalveolar inflammation following endotoxemia. | 1985 | Circ. Shock | pmid:4053294 |
| Leffler CW and Busija DW | Prostanoids in cortical subarachnoid cerebrospinal fluid and pial arterial diameter in newborn pigs. | 1985 | Circ. Res. | pmid:4053302 |
| Ment LR et al. | Beagle puppy model of perinatal cerebral infarction. Acute changes in regional cerebral prostaglandins during hemorrhagic hypotension. | 1985 | J. Neurosurg. | pmid:4056903 |
| Katoh K et al. | [Serial changes in plasma thromboxane and complement in ARDS--effect of the thromboxane synthetase inhibitor]. | 1985 | Masui | pmid:4057547 |
| Purkerson ML et al. | Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation. | 1985 | Proc. Natl. Acad. Sci. U.S.A. | pmid:3855542 |
| Jackson EK | Effects of thromboxane synthase inhibition on vascular responsiveness in the in vivo rat mesentery. | 1985 | J. Clin. Invest. | pmid:4077980 |
| Dempsey RJ et al. | Polyamine and prostaglandin markers in focal cerebral ischemia. | 1985 | Neurosurgery | pmid:3864030 |
| Dahl ML and Uotila P | Sodium salicylate does not prevent the inhibitory effect of indomethacin on thromboxane formation in human blood ex vivo. | 1985 | Prostaglandins Leukot Med | pmid:3856282 |
| Kääpä P | Immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in neonatal hyperbilirubinemia. | 1985 | Prostaglandins Leukot Med | pmid:3856285 |
| Zijlstra FJ and Vincent JE | Leukotriene D4 and phospholipase A2 release thromboxane A2 of different origin in the guinea pig lung parenchymal strip. | 1985 | Prostaglandins Leukot Med | pmid:3857642 |
| Salmon JA et al. | Evaluation of inhibitors of eicosanoid synthesis in leukocytes: possible pitfall of using the calcium ionophore A23187 to stimulate 5' lipoxygenase. | 1985 | Prostaglandins | pmid:2988019 |
| Hutchison AA et al. | Plasma 6-keto prostaglandin F1 alpha and thromboxane B2 in sick preterm neonates. | 1985 | Prostaglandins Leukot Med | pmid:3859877 |